enFive is a meningococcal (A, C, Y, W, X) polysaccharide conjugate vaccine manufactured by Serum Institute of India. It is developed to support prevention of invasive meningococcal disease, including meningitis and septicaemia. A key differentiator is its inclusion of serogroup X along with A, C, Y, and W. The image provided shows the product vial presentation, which helps distinguish MenFive from the other vaccine products listed here.